Logo image of MKGI

Monaker Group Inc (MKGI) Stock Fundamental Analysis

USA - NASDAQ:MKGI -

2.27
+0.15 (+7.08%)
Last: 7/8/2021, 8:22:39 PM
2.27
0 (0%)
After Hours: 7/8/2021, 8:22:39 PM
Fundamental Rating

2

Taking everything into account, MKGI scores 2 out of 10 in our fundamental rating. MKGI was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of MKGI is average, but there are quite some concerns on its profitability. MKGI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MKGI has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -63.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -16499.59%
PM (TTM) -34188.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

MKGI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -4.30, we must say that MKGI is in the distress zone and has some risk of bankruptcy.
MKGI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.3
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

MKGI has a Current Ratio of 1.89. This is a normal value and indicates that MKGI is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.89 indicates that MKGI should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.89

More info and screens

4

3. Growth

3.1 Past

The earnings per share for MKGI have decreased strongly by -23.90% in the last year.
Looking at the last year, MKGI shows a very negative growth in Revenue. The Revenue has decreased by -89.07% in the last year.
MKGI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -38.40% yearly.
EPS 1Y (TTM)-23.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-860%
Revenue 1Y (TTM)-89.07%
Revenue growth 3Y-51.78%
Revenue growth 5Y-38.4%
Sales Q2Q%-99.28%

3.2 Future

The Earnings Per Share is expected to grow by 10.07% on average over the next years. This is quite good.
MKGI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 268.67% yearly.
EPS Next Y48.48%
EPS Next 2Y23.95%
EPS Next 3Y13.64%
EPS Next 5Y10.07%
Revenue Next Year1300.01%
Revenue Next 2Y447.73%
Revenue Next 3Y319.63%
Revenue Next 5Y268.67%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MKGI Yearly Revenue VS EstimatesMKGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
MKGI Yearly EPS VS EstimatesMKGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MKGI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MKGI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MKGI Price Earnings VS Forward Price EarningsMKGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -7.18
MKGI Per share dataMKGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as MKGI's earnings are expected to grow with 13.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3Y13.64%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MKGI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Monaker Group Inc

NASDAQ:MKGI (7/8/2021, 8:22:39 PM)

After market: 2.27 0 (0%)

2.27

+0.15 (+7.08%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.37%
Inst Owner Change19.85%
Ins Owners23.57%
Ins Owner Change0%
Market Cap53.47M
Analysts0
Price Target5.87 (158.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1106.99
P/FCF N/A
P/OCF N/A
P/B 2.79
P/tB N/A
EV/EBITDA -7.18
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.81
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -16499.59%
PM (TTM) -34188.82%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.89
Altman-Z -4.3
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-860%
EPS Next Y48.48%
EPS Next 2Y23.95%
EPS Next 3Y13.64%
EPS Next 5Y10.07%
Revenue 1Y (TTM)-89.07%
Revenue growth 3Y-51.78%
Revenue growth 5Y-38.4%
Sales Q2Q%-99.28%
Revenue Next Year1300.01%
Revenue Next 2Y447.73%
Revenue Next 3Y319.63%
Revenue Next 5Y268.67%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A